Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002

被引：54

作者：

Prabhu, RM

Piper, KE

Baddour, LM

Steckelberg, JM

Wilson, WR

Patel, R

机构：

[1] Mayo Clin, Coll Med, Div Infect Dis, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA

[3] Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 11期

关键词：

D O I：

10.1128/AAC.48.11.4463-4465.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

To determine whether changes in antimicrobial resistance have occurred among viridans group streptococci, we retrospectively examined 50 viridans group streptococcal isolates recovered from patients with infective endocarditis over 3 decades. Resistance rates (percent resistant isolates 1971 to 1986 and 1994 to 2002) were as follows: levofloxacin, 0 and 9; penicillin and clindamycin, 0 and 4; and erythromycin and azithromycin, 11 and 26, respectively.

引用

收藏

页码：4463 / 4465

页数：3

相关论文

共 28 条

[1] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCUS IN NEUTROPENIC PATIENTS WITH CANCER - CLINICAL SPECTRUM AND RISK-FACTORS [J].

BOCHUD, PY ;

EGGIMAN, P ;

CALANDRA, T ;

VANMELLE, G ;

SAGHAFI, L ;

FRANCIOLI, P .

CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :25-31

[2] ANTI-MICROBIAL SUSCEPTIBILITIES OF SPECIES OF VIRIDANS STREPTOCOCCI [J].

BOURGAULT, AM ;

WILSON, WR ;

WASHINGTON, JA .

JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (03) :316-321

[3] RANDOMIZED TRIAL OF THE ADDITION OF GRAM-POSITIVE PROPHYLAXIS TO STANDARD ANTIMICROBIAL PROPHYLAXIS FOR PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

BROUN, ER ;

WHEAT, JL ;

KNEEBONE, PH ;

SUNDBLAD, K ;

HROMAS, RA ;

TRICOT, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :576-579

[4] STREPTOCOCCUS-MITIS SEPSIS IN BONE-MARROW TRANSPLANT PATIENTS RECEIVING ORAL ANTIMICROBIAL PROPHYLAXIS [J].

CLASSEN, DC ;

BURKE, JP ;

FORD, CD ;

EVERSHED, S ;

ALOIA, MR ;

WILFAHRT, JK ;

ELLIOTT, JA .

AMERICAN JOURNAL OF MEDICINE, 1990, 89 (04) :441-446

[5] In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada [J].

de Azavedo, JCS ;

Trpeski, L ;

Pong-Porter, S ;

Matsumura, S ;

Low, DE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2299-2301

[6] Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America [J].

Diekema, DJ ;

Beach, ML ;

Pfaller, MA ;

Jones, RN .

CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) :152-157

[7] Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States [J].

Doern, GV ;

Ferraro, MJ ;

Brueggemann, AB ;

Ruoff, KL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :891-894

[8] BACTEREMIA DUE TO ORAL VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH CANCER - CYTOSTATICS ARE A MORE IMPORTANT RISK FACTOR THAN ANTIBACTERIAL PROPHYLAXIS [J].

DONNELLY, JP ;

DOMPELING, EC ;

MEIS, JF ;

DEPAUW, BE .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :469-470

[9] SEPTICEMIA AND SHOCK SYNDROME DUE TO VIRIDANS STREPTOCOCCI - A CASE-CONTROL STUDY OF PREDISPOSING FACTORS [J].

ELTING, LS ;

BODEY, GP ;

KEEFE, BH .

CLINICAL INFECTIOUS DISEASES, 1992, 14 (06) :1201-1207

[10] What happened to the streptococci: Overview of taxonomic and nomenclature changes [J].

Facklam, R .

CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (04) :613-+